What’s the Real Reason Drug Prices Are So High In America?

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


This hardly seems important at the moment, but Sarah Kliff mentioned something today that’s always bugged me. She’s explaining why prescription drugs cost a lot more in the US than elsewhere, and concludes that it’s because other countries all negotiate drug prices at a national level and we don’t:

The United States has no government panel that negotiates drug prices. There are thousands of health insurance plans all across the country. Each has to negotiate its own prices with drugmakers separately. Because Americans are fragmented across all these different health insurers, plans have much less bargaining power to demand lower prices. In other words: Australia is buying drugs in bulk, like you would at Costco, while we’re picking up tiny bottles at the local pharmacy. You can guess who is paying more.

OK, but take a look at the stick figure on the right, part of Vox’s latest innovation in explanatory journalism. The country with the lowest drug spending is Denmark, population 6 million. Compare that to Blue Cross, which insures about 100 million people. United Healthcare insures about 70 million. Aetna insures about 20 million. Kaiser Permanente clocks in around 10 million.

In other words, all of these health insurers are as big as whole countries. And they’re way bigger than little Denmark. So why are they unable to negotiate lower drug prices? Medicare may be prohibited from doing this, but private insurers aren’t.

Are insurers hemmed in by rules requiring them to offer any “medically necessary” drug? Are they, ironically, limited by competition—afraid of losing customers if they don’t cover everything? Are they just lousy negotiators because they don’t really care? After all, high prices are going to get passed along anyway, so it doesn’t hurt them as long as their competitors are in the same boat.

Alternatively, do I completely misunderstand how the process works?

My gripe with this is not so much that drug prices are high. My gripe is that the US essentially subsidizes the rest of the world. Pharmaceutical companies require a certain overall return on their invested capital, but they don’t care where it comes from. If prices are low in Europe and high in the US, that’s fine. If prices in the US came down, they’d make up for it by raising prices in Europe—and that would be fine too.

So why not put America First, to coin a phrase, and push down prices here? It wouldn’t hurt the drug companies, it would just force them to raise prices elsewhere. That would be fine with me. I’ve never really understood why we’re in the business of helping Europe pay less for drugs.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate